Back
Hamilton Enhanced Multi-Sect Cov Cll ETF Quote, Financials, Valuation and Earnings
Sponsored
HDIV.TO
Sponsored
Alex Green's "Next Magnificent Seven" AI Stocks-Turn $7,000 into $1 Million!
Watch Alex's presentation and discover the AI stocks set to dominate!
Sell
50
HDIV.TO
Hamilton Enhanced Multi-Sect Cov Cll ETF
Last Price:
17.26
Seasonality Move:
6.58%
7 Day Trial
ALL ACCESS PASS
$
7
Invest in the Next Big AI Disruptor Today
Learn MoreHamilton Enhanced Multi-Sect Cov Cll ETF Price Quote
$17.26
-0.13 (-0.75%)
(Updated: September 30, 2024 at 10:25 AM ET)
Hamilton Enhanced Multi-Sect Cov Cll ETF Key Stats
Sell
50
Hamilton Enhanced Multi-Sect Cov Cll ETF (HDIV.TO)
is a Sell
Day range:
$17.35 - $17.50
52-week range:
$14.00 - $17.57
Dividend yield:
10.83%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0%
Volume:
83.4K
Avg. volume:
82.7K
1-year change:
17.58%
Market cap:
$0
Revenue:
$0
EPS:
$0
How Much Does Hamilton Enhanced Multi-Sect Cov Cll ETF Make?
Data Unavailable
Is Hamilton Enhanced Multi-Sect Cov Cll ETF Growing As A Company?
Data Unavailable
Hamilton Enhanced Multi-Sect Cov Cll ETF Stock Price Performance
-
Did Hamilton Enhanced Multi-Sect Cov Cll ETF Stock Go Up Last Month?
Hamilton Enhanced Multi-Sect Cov Cll ETF share price went up by 2.35% last month -
Did HDIV.TO's Share Price Rise Over The Last Year?
HDIV.TO share price rose by 17.58% over the past 1 year
What Is Hamilton Enhanced Multi-Sect Cov Cll ETF 52-Week High & Low?
-
What Is Hamilton Enhanced Multi-Sect Cov Cll ETF’s 52-Week High Share Price?
Hamilton Enhanced Multi-Sect Cov Cll ETF has traded as high as $17.57 over the past 52 weeks -
What Is Hamilton Enhanced Multi-Sect Cov Cll ETF’s 52-Week Low Share Price?
Hamilton Enhanced Multi-Sect Cov Cll ETF has traded as low as $14.00 over the past 52 weeks
Hamilton Enhanced Multi-Sect Cov Cll ETF Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Hamilton Enhanced Multi-Sect Cov Cll ETF?
Data Unavailable
Is Hamilton Enhanced Multi-Sect Cov Cll ETF Cash Flow Positive?
Data Unavailable
Hamilton Enhanced Multi-Sect Cov Cll ETF Return On Invested Capital
Data Unavailable
Hamilton Enhanced Multi-Sect Cov Cll ETF Earnings Date & Stock Price
-
What Is Hamilton Enhanced Multi-Sect Cov Cll ETF's Stock Price Today?
A single share of HDIV.TO can be purchased today for 17.39 -
What Is Hamilton Enhanced Multi-Sect Cov Cll ETF’s Stock Symbol?
Hamilton Enhanced Multi-Sect Cov Cll ETF trades on the tsx under the ticker symbol: HDIV.TO -
When Is Hamilton Enhanced Multi-Sect Cov Cll ETF’s Next Earnings Date?
The next quarterly earnings date for Hamilton Enhanced Multi-Sect Cov Cll ETF is scheduled on September 30, 2024 -
When Is HDIV.TO's next ex-dividend date?
Hamilton Enhanced Multi-Sect Cov Cll ETF's next ex-dividend date is September 27, 2024 -
How To Buy Hamilton Enhanced Multi-Sect Cov Cll ETF Stock?
You can buy Hamilton Enhanced Multi-Sect Cov Cll ETF shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Hamilton Enhanced Multi-Sect Cov Cll ETF Competitors
-
Who Are Hamilton Enhanced Multi-Sect Cov Cll ETF's Competitors?
Below is a list of companies who compete with Hamilton Enhanced Multi-Sect Cov Cll ETF or are related in some way:
Hamilton Enhanced Multi-Sect Cov Cll ETF Dividend Yield
-
What Is HDIV.TO Dividend Yield?
Hamilton Enhanced Multi-Sect Cov Cll ETF’s dividend yield currently is 10.83% -
What Is Hamilton Enhanced Multi-Sect Cov Cll ETF’s Payout Ratio?
Hamilton Enhanced Multi-Sect Cov Cll ETF’s payout ratio is 0% -
When Did Hamilton Enhanced Multi-Sect Cov Cll ETF Last Pay A Dividend?
The latest dividend pay date is September 30, 2024 -
What Is Hamilton Enhanced Multi-Sect Cov Cll ETF’s Dividend Per Share?
Hamilton Enhanced Multi-Sect Cov Cll ETF pays a dividend of $0.00 per share
Hamilton Enhanced Multi-Sect Cov Cll ETF Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | 0% |
Revenue: | 0% | 0% |
Analyst Recommendations
Buy Recommendations: | 0 |
---|---|
Hold Recommendations: | 0 |
Sell Recommendations: | 0 |
Price Target: | 0.00 |
Downside from Last Price: | -100% |
Major Shareholders
Data Unavailable